Cite
HARVARD Citation
Kameda, T. et al. (n.d.). AB0197 Evaluation of Serum IL-10 and IP-10 Levels Is Useful as Prognostic Biomarkers for Selection of IL-6R Antibody (TCZ) Prior To Tumor Necrosis Factor (TNF) Inhibitor in Rheumatoid Arthritis Treatment. Annals of the rheumatic diseases. pp. 964-965. [Online].